Pexeva (paroxetine mesylate) tablet
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- January 2009, and April 2011
|The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.|
- ...tamoxifen drug interaction...
Before starting Pexeva, tell your healthcare provider if you:
- ...tamoxifen... added
Summary of Changes to Contraindications and Warnings